HeimOPL • ASX
add
Opyl Ltd
Við síðustu lokun
0,026 $
Árabil
0,014 $ - 0,033 $
Markaðsvirði
4,52 m. AUD
Meðalmagn
147,09 þ.
V/H-hlutf.
-
A/V-hlutfall
-
Aðalkauphöll
ASX
Viðskiptafréttir
Fjármál
Rekstrarreikningur
Tekjur
Nettótekjur
| (AUD) | des. 2024info | Breyting á/á |
|---|---|---|
Tekjur | 21,07 þ. | -82,70% |
Rekstrarkostnaður | 176,95 þ. | -22,08% |
Nettótekjur | -341,60 þ. | 46,47% |
Hagnaðarhlutfall | -1,62 þ. | -209,51% |
Hagnaður á hvern hlut | — | — |
EBITDA | -318,25 þ. | 25,33% |
Virkt skatthlutfall | — | — |
Efnahagsreikningur
Heildareignir
Heildarskuldir
| (AUD) | des. 2024info | Breyting á/á |
|---|---|---|
Reiðufé og skammtímafjárfestingar | 329,55 þ. | -43,64% |
Heildareignir | 384,82 þ. | -41,63% |
Heildarskuldir | 695,82 þ. | -3,76% |
Eigið fé alls | -310,99 þ. | — |
Útistandandi hlutabréf | 192,86 m. | — |
Eiginfjárgengi | ∞ | — |
Arðsemi eigna | -208,60% | — |
Ávöxtun eigin fjár | -683,65% | — |
Peningaflæði
Breyting á handbæru fé
| (AUD) | des. 2024info | Breyting á/á |
|---|---|---|
Nettótekjur | -341,60 þ. | 46,47% |
Handbært fé frá rekstri | -309,99 þ. | -6,88% |
Reiðufé frá fjárfestingum | -662,00 | — |
Reiðufé frá fjármögnun | 288,10 þ. | -19,06% |
Breyting á handbæru fé | -22,55 þ. | -134,21% |
Frjálst peningaflæði | -200,88 þ. | 17,96% |
Um
Opyl is a Melbourne-based company listed on the Australian Securities Exchange that applies artificial intelligence to improving clinical trial efficiencies. The company has two key platforms: Opin a global clinical trial recruitment platform and service as well as TrialKey a Saas software as a service platform that predicts and designs optimized clinical trial protocols, reducing the risk of failure and improving a return on investment in new and emerging medicines, devices, and diagnostics..
Opyl is a rebrand and strategic realignment from a former company known as ShareRoot, a US-based martech platform that secured rights to user-generated content on social media, predominantly used by big brands that collaborated with influencers.
Before going public in 2016, ShareRoot had previously participated in 500 Startups batch 8 and raised a round of angel investing.
ShareRoot was rebranded to Opyl in 2020 to work on technology to support the health and life sciences sector. Wikipedia
Stofnsett
2013
Vefsvæði
Starfsfólk
3
